BOSTON — Sept. 26, 2016 — On Thursday, Sept. 29, 2016, Dr. Fang Xie, patent attorney and of counsel in Greenberg Traurig, LLP’s Boston office, will be a panelist on the session “Managing Intellectual Property in Asia” at the Trans-Pacific Health Sciences Dialogue conference at Harvard Medical School, Boston. During the session, panelists will discuss challenges and opportunities for biotech companies, including retaining US commercialization rights in license deals.
Dr. Xie is a member of the firm’s global Life Sciences & Medical Technology Group. Recently listed in IAM Strategy 300 – The World’s Leading IP Strategists, Dr. Xie focuses her practice on life sciences & technology‐driven transactions involving the establishing, licensing, sharing, development, and monetization of various intellectual property rights. She has broad experience in worldwide patent and trademark portfolio development, intellectual property due diligence, licensing and technology transfer, patentability and product clearance studies, patent infringement and validity analyses, freedom to operate evaluations, as well as intellectual property litigation and pre-litigation counseling.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: www.gtlaw.com Twitter: @GT_Law.